Skip to main content

Table 4 Univariate and multivariate analyses for late recurrence in all cases (late vs no recurrence)

From: Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence

  Late vs no recurrence
  Univariate analysis p Value Multivariate analysis p Value
ALDH1, ≤1 %/>1 % 1.689 (0.883–3.164) 0.110 1.507 (0.738–2.998) 0.253
Bilateral breast cancer absent/present 17.136 (4.645–110.57) <0.001 18.952 (4.812–126.55) <0.001
Menopausal status pre/post 0.745 (0.493–1.121) 0.159 0.731 (0.464–1.144) 0.171
Tumor size, ≤20/>20 mm 2.854 (1.878–4.387) <0.001 2.356 (1.495–3.749) <0.001
Nodal metastasis negative/positive 3.442 (2.193–5.421) <0.001 2.940 (1.809–4.790) <0.001
Tumor grade 1 or 2/3 1.707 (1.001–2.877) 0.046 1.316 (0.727–2.339) 0.358
  1. ALDH1 aldehyde dehydrogenase 1